Skip to nav Skip to content

Policy & Advocacy

IDSA promotes science-based public policy to advance U.S. and global efforts on antimicrobial resistance, immunization, infection prevention and control, HIV/AIDS, tuberculosis, public health emergencies, and other ID issues. The Society supports federal funding for research and public health, and appropriate reimbursement and coverage of ID services.

Learn about IDSA’s policy and advocacy efforts, with links to relevant policy documents, reports, and websites. See the key policy focus areas below.

Access & Reimbursement

Fair and adequate reimbursement for infectious diseases physicians is a key IDSA policy priority. The Society also advocates for access to appropriate treatments for patients with serious infections and for medical liability reform. 


Antibiotic Resistance

Antibiotic development; strengthening U.S. antimicrobial resistance efforts, including surveillance, prevention and control, data collection and research; antimicrobial stewardship; antimicrobials in agriculture.


Diagnostics

IDSA is committed to supporting improved diagnostics including providing recommendations to spur research and development of new tests, and encouraging their use in patient care and public health.


Emerging Infections and Biothreat

Influenza, other emerging infections, and bio-threats; U.S. preparedness and response, public health and research efforts, countermeasures (vaccines, drugs and diagnostics), non-therapeutic control measures. 


Funding Policy

Funding for domestic and international ID programs, including antimicrobial resistance; immunization; drug, vaccine, and diagnostics development; and prevention and treatment of new and emerging infections.


Global Health

IDSA prioritizes promoting sufficient U.S. investment in global infectious diseases responses and research, and in using the voices of physician scientists to inform multilateral and national global health policies. 


Immunization & Vaccination

Supporting national immunization programs for children, adolescents, and adults, including health care workers; advancing research and development of new and improved vaccines.


Infection Prevention & Control

Evidence-based practices and policies to prevent and control health care-associated infections (HAIs). 


Research & Infrastructure

Advancing biomedical and public health research priorities; supporting infrastructure that enables and strengthens ID research, clinical, and prevention efforts. 


Workforce Policy

Developing and maintaining a workforce of ID clinicians, researchers, and public health experts.


This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.